Viewing Study NCT01526694


Ignite Creation Date: 2025-12-25 @ 1:32 AM
Ignite Modification Date: 2025-12-25 @ 11:46 PM
Study NCT ID: NCT01526694
Status: COMPLETED
Last Update Posted: 2018-07-03
First Post: 2012-01-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Trial Designed to Determine Efficacy and Safety of Bendamustine+Dexamethasone+Thalidomide in R/R MM
Sponsor: Azienda Ospedaliera di Bolzano
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module